🔗 Share this article Social Media Influencers Driving Unofficial Trade for Unlicensed Slimming Drug An underground economy for unapproved slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations. Experimental Drug Acquiring Popularity Via Social Media The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are encouraged to message these profiles privately for source information, while also obtaining promotional offers. Active Commerce on Social Networks Additionally, a flourishing market exists on Telegram, where communities with numerous of participants share comparison photos, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing customers to WhatsApp for purchases. Learning About The Experimental Drug This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic. Medical Experts Express Worries Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin. Some professionals said the popularity for the experimental drug could be linked to the rising price of approved slimming products such as Mounjaro. Regulatory Position and Enforcement Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the British medical regulations. Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or prison. Service Reaction and Material Removal Based on the social media company, the service has removed violative content and prohibited associated keywords and query recommendations. The company said it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies. Online Marketplace Operations Investigations also found communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for mixing or injecting at home. Within moments of entering one group, a vendor posted WhatsApp details, where most purchases occur. The vendor provided an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience. Product Information and Costs Within these groups, posts display dark colored packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.” Customers can choose between powder vials, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how long a injector should last, sellers give contradictory answers ranging from a several days to “depends on your body”. Platform Oversight and Safety Measures A spokesperson for the messaging service stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”. Medical Expert Cautions “People are administering substances they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said. Her staff has already seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.” Manufacturer Statement A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental product not yet approved … may expose users to possibly serious medical dangers”.